Menthyl Lactate CAS 17162-29-7 cooling agent China Manufacturer

Menthyl Lactate Cooling Efficiency vs Concentration

This chart presents a comparative analysis of Menthyl Lactate cooling efficiency and perceived skin comfort across a range of formulation concentrations (0.1%, 0.25%, 0.5%, 0.75%, 1.0%). The x-axis shows concentration by weight percent; the left y-axis indicates relative cooling intensity (arbitrary units normalized for comparative purposes), and the right y-axis denotes perceived skin comfort on a 0–100 scale. Data are hypothetical but reflect common formulation behavior: cooling intensity rises with increasing concentration and exhibits diminishing returns beyond intermediate levels, while perceived comfort peaks at low-to-moderate concentrations and declines at higher loadings due to potential sensory irritation or overactivation of cooling receptors. Key observations: cooling intensity increases steeply from 0.1% to 0.5%, then begins to plateau between 0.5% and 1.0%, indicating that formulations above approximately 0.5% yield smaller incremental cooling benefits. Perceived skin comfort decreases gradually after 0.25% and more sharply beyond 0.5%, suggesting a tradeoff where higher cooling may compromise user comfort. The intersection region around 0.25%–0.5% represents an optimal balance where significant cooling is achieved while maintaining acceptable comfort scores. For formulators and OEM partners, this type of dual-metric analysis supports evidence-based selection of target concentrations. Selecting a concentration in the 0.25%–0.5% range can maximize sensory impact while minimizing adverse comfort effects and potential regulatory or safety concerns associated with higher loadings. Additional considerations include vehicle composition, application area, exposure duration, and population sensitivity; final decisions should be validated with targeted sensory panels and stability/safety testing. The chart therefore serves as a decision-support visualization to guide iterative formulation optimization. Where regulatory constraints or targeted product claims require specific cooling thresholds, manufacturers should incorporate objective analytical assays such as in vitro receptor activation, standardized time–intensity sensory panels, and controlled repeat-exposure studies to substantiate performance and safety. Iterative testing combined with consumer feedback ensures robust, market-ready sensory profiles.